Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01931904 · ClinicalTrials.gov registry record
Eye Pressure Lowering Surgery
A clinical trial of Glaucoma, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- 46
- Enrollment target
- 1
- Study location
NCT01931904 is a study of Glaucoma that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 46 participants, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01931904, a study of Glaucoma, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- 46 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if lowering the pressure inside the eye improves blood flow to the eye.
Conditions Studied
Study Locations (1)
Oregon
- OHSU - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2014-02-01 |
| Est. Completion | 2026-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01931904
The ClinicalTrials.gov registry entry for NCT01931904 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 910-participant average among 92 other Glaucoma trials with a reported enrollment target (95% lower). The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 0 interventions.
NCT01931904 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT01931904 about?
NCT01931904 is a clinical study titled "Eye Pressure Lowering Surgery". The purpose of this study is to determine if lowering the pressure inside the eye improves blood flow to the eye.
What is the current status of trial NCT01931904?
This trial is currently recruiting. The enrollment target is 46 participants. The study started on 2014-02-01. Estimated completion is 2026-05.
What conditions does trial NCT01931904 study?
This clinical trial studies the following conditions: Glaucoma.
Who is sponsoring clinical trial NCT01931904?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01931904 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Functional and Structural Imaging for Glaucoma
RECRUITING
-
Topical Insulin for Glaucoma
RECRUITING · Phase 1
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 2
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
-
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.